Trial Details

COMPLETED
Basic Information
Clinical ID c4485
Identifier NCT00446433
Trial Title A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: CC-5013
Participant Information
Sponsor Celgene Corporation
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2002-03
Primary Completion Date -
Completion Date 2003-12